iFirst Medical Technologies

📍 Honolulu, United States🗓 Founded 2016👥 6 employees💰 Last funded Sep 2017
Providing a new standard-of-care in coagulation diagnostics. Modernized coagulation testing that can characterize patient physiological data such as anticoagulants, ethnicity and care history. Existing tests such as PT/INR do not provide the sensitivity or depth of information needed in critical care applications such as traumatic injury or surgical monitoring. Simple to use, mobile and inexpensive; iFirst’s “mobile lab” will enable lifesaving information to be transmitted to the hospital prior to patient arrival. Blood products can be selected as the patient is en-route. iFirst envisions the growth of products using a mobile health diagnostic platform and continues to pursue its application for other critical situations; where ease of use, cost, and mobility can help save lives of patients and provide care-providers increase profits.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in iFirst Medical Technologies?
iFirst Medical Technologies has 3 investors on record on gritt.io, including 3 early-stage backers.
When did iFirst Medical Technologies last raise funding?
The most recent investment in iFirst Medical Technologies recorded on gritt.io was in September 2017.
When was iFirst Medical Technologies founded?
iFirst Medical Technologies was founded in 2016.
What industry is iFirst Medical Technologies in?
iFirst Medical Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is iFirst Medical Technologies based?
iFirst Medical Technologies is headquartered in Honolulu, United States.